On today’s podcast, host Wayne Bowden, Vice President of Partnerships and Strategy at Biorasi, talks with Marianne Clancy, Executive Director at Cure HHT, about the foundation and their goal of reducing the number of undiagnosed cases of HHT.
“Our studies are open for those that have exhausted standard of care, and we're showing improved responses, and the data is promising. So, I...
"In research or in biotech, time is expensive. Time is the most expensive thing that you have." - Stephanie Wisner, Author, Co-Founder at Centivax...
"I hope we're moving into the age of the generalist, where knowing how to learn and learning how to learn are more important than...